Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-014592
Filing Date
2023-02-08
Accepted
2023-02-08 17:00:58
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm235112-4_5seq1.html 5  
1 OWNERSHIP DOCUMENT tm235112-4_5seq1.xml 5 3209
  Complete submission text file 0001104659-23-014592.txt   4641
Mailing Address 1119 ST PAUL ST BALTIMORE MD 21202
Business Address
NEWHALL CHARLES W III (Reporting) CIK: 0001005544 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35518 | Film No.: 23599923

Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations